These include: (1) CASY-1/calsyntenin: expression level of calsyntenin-1 or −3 was altered in the human brain or mouse model of Alzheimer’s disease (Uchida et al., 2011; Vagnoni et al., 2012). This evidence concerns the gene CLSTN1 and Alzheimer disease.